ATE475661T1 - Triazolopyridin-carboxamid-derivate sowie ihre herstellung und therapeutische verwendung - Google Patents

Triazolopyridin-carboxamid-derivate sowie ihre herstellung und therapeutische verwendung

Info

Publication number: ATE475661T1
Authority: AT; Austria
Prior art keywords: production; therapeutic use; carboxamide derivatives; triazolopyridine; triazolopyridine carboxamide
Prior art date: 2007-04-18

Application number

AT08787964T

Other languages

English (en)

Inventor

Christian Hoornaert

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-18

Filing date

2008-04-16

Publication date

2010-08-15

2008-04-16 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2010-08-15 Application granted granted Critical

2010-08-15 Publication of ATE475661T1 publication Critical patent/ATE475661T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Oncology (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Anesthesiology (AREA)
Tropical Medicine & Parasitology (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Virology (AREA)
Vascular Medicine (AREA)

AT08787964T 2007-04-18 2008-04-16 Triazolopyridin-carboxamid-derivate sowie ihre herstellung und therapeutische verwendung ATE475661T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0702807A FR2915197B1 (fr)	2007-04-18	2007-04-18	Derives de triazolopyridine-carboxamides, leur preparation et leur application therapeutique.
PCT/FR2008/000535 WO2008145842A2 (fr)	2007-04-18	2008-04-16	Dérivés de triazolopyridine-carboxamides, leur préparation et leur application en thérapeutique

Publications (1)

Publication Number	Publication Date
ATE475661T1 true ATE475661T1 (de)	2010-08-15

Family

ID=38739381

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT08787964T ATE475661T1 (de)	2007-04-18	2008-04-16	Triazolopyridin-carboxamid-derivate sowie ihre herstellung und therapeutische verwendung

Country Status (26)

Country	Link
US (2)	US7868007B2 (de)
EP (1)	EP2146991B1 (de)
JP (1)	JP2010524907A (de)
KR (1)	KR20090130060A (de)
CN (1)	CN101657451A (de)
AR (1)	AR066103A1 (de)
AT (1)	ATE475661T1 (de)
AU (1)	AU2008257323A1 (de)
BR (1)	BRPI0810430A2 (de)
CA (1)	CA2683933A1 (de)
CY (1)	CY1111601T1 (de)
DE (1)	DE602008001981D1 (de)
DK (1)	DK2146991T3 (de)
ES (1)	ES2348969T3 (de)
FR (1)	FR2915197B1 (de)
HR (1)	HRP20100573T1 (de)
IL (1)	IL201416A0 (de)
MX (1)	MX2009011215A (de)
PL (1)	PL2146991T3 (de)
PT (1)	PT2146991E (de)
RS (1)	RS51462B (de)
RU (1)	RU2009142430A (de)
SI (1)	SI2146991T1 (de)
TW (1)	TW200906401A (de)
UY (1)	UY31036A1 (de)
WO (1)	WO2008145842A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2743861A1 (en) *	2008-11-14	2010-05-20	The Scripps Research Institute	Methods and compositions related to targeting monoacylglycerol lipase
SG172301A1 (en)	2008-12-24	2011-07-28	Bial Portela & Ca Sa	Pharmaceutical compounds
WO2010124082A1 (en) *	2009-04-22	2010-10-28	Janssen Pharmaceutica Nv	Azetidinyl diamides as monoacylglycerol lipase inhibitors
WO2011140296A1 (en) *	2010-05-05	2011-11-10	Infinity Pharmaceuticals	Triazoles as inhibitors of fatty acid synthase
BR112013005141A2 (pt)	2010-09-03	2016-05-10	Janssen Pharmaceutica Nv	diazetidinil diamida como inibidores de monoacilglicerol lipase
WO2012044613A1 (en)	2010-09-27	2012-04-05	Janssen Pharmaceutica Nv	Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
RU2013123274A (ru)	2010-10-22	2014-11-27	Янссен Фармацевтика Нв	Аминопирролидиназетидиндиамиды как ингибиторы моноацилглицеринлипазы
US8513423B2 (en)	2010-10-22	2013-08-20	Janssen Pharmaceutica, Nv	Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors
EP2567959B1 (de)	2011-09-12	2014-04-16	Sanofi	6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamid-derivate als kinaseinhibitoren
MA53722A (fr)	2018-09-28	2022-03-30	Janssen Pharmaceutica Nv	Modulateurs de la monoacylglycérol lipase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0100624D0 (en) *	2001-01-10	2001-02-21	Vernalis Res Ltd	Chemical compounds VII
DE10247680B4 (de) *	2002-10-12	2005-09-01	Aventis Pharma Deutschland Gmbh	Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase
DE102004005172A1 (de) *	2004-02-02	2005-08-18	Aventis Pharma Deutschland Gmbh	Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
US7632837B2 (en) *	2005-06-17	2009-12-15	Bristol-Myers Squibb Company	Bicyclic heterocycles as cannabinoid-1 receptor modulators
DE102005049954A1 (de) *	2005-10-19	2007-05-31	Sanofi-Aventis Deutschland Gmbh	Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen

2007
- 2007-04-18 FR FR0702807A patent/FR2915197B1/fr not_active Expired - Fee Related
2008
- 2008-04-16 CN CN200880012319A patent/CN101657451A/zh active Pending
- 2008-04-16 ES ES08787964T patent/ES2348969T3/es active Active
- 2008-04-16 AT AT08787964T patent/ATE475661T1/de active
- 2008-04-16 MX MX2009011215A patent/MX2009011215A/es active IP Right Grant
- 2008-04-16 SI SI200830079T patent/SI2146991T1/sl unknown
- 2008-04-16 RS RSP-2010/0434A patent/RS51462B/en unknown
- 2008-04-16 DE DE602008001981T patent/DE602008001981D1/de active Active
- 2008-04-16 WO PCT/FR2008/000535 patent/WO2008145842A2/fr active Application Filing
- 2008-04-16 EP EP08787964A patent/EP2146991B1/de active Active
- 2008-04-16 DK DK08787964.9T patent/DK2146991T3/da active
- 2008-04-16 JP JP2010503550A patent/JP2010524907A/ja active Pending
- 2008-04-16 PT PT08787964T patent/PT2146991E/pt unknown
- 2008-04-16 CA CA002683933A patent/CA2683933A1/fr not_active Abandoned
- 2008-04-16 AU AU2008257323A patent/AU2008257323A1/en not_active Abandoned
- 2008-04-16 PL PL08787964T patent/PL2146991T3/pl unknown
- 2008-04-16 BR BRPI0810430-1A2A patent/BRPI0810430A2/pt not_active IP Right Cessation
- 2008-04-16 RU RU2009142430/04A patent/RU2009142430A/ru not_active Application Discontinuation
- 2008-04-16 KR KR1020097021600A patent/KR20090130060A/ko not_active Application Discontinuation
- 2008-04-17 TW TW097114016A patent/TW200906401A/zh unknown
- 2008-04-18 UY UY31036A patent/UY31036A1/es not_active Application Discontinuation
- 2008-04-18 AR ARP080101597A patent/AR066103A1/es unknown
2009
- 2009-10-06 US US12/573,961 patent/US7868007B2/en not_active Expired - Fee Related
- 2009-10-11 IL IL201416A patent/IL201416A0/en unknown
2010
- 2010-10-05 CY CY20101100884T patent/CY1111601T1/el unknown
- 2010-10-19 HR HR20100573T patent/HRP20100573T1/hr unknown
- 2010-11-30 US US12/956,764 patent/US20110071161A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PL2146991T3 (pl)	2011-01-31
WO2008145842A2 (fr)	2008-12-04
PT2146991E (pt)	2010-10-04
US20100035893A1 (en)	2010-02-11
US20110071161A1 (en)	2011-03-24
JP2010524907A (ja)	2010-07-22
CY1111601T1 (el)	2015-10-07
FR2915197A1 (fr)	2008-10-24
CN101657451A (zh)	2010-02-24
ES2348969T3 (es)	2010-12-17
BRPI0810430A2 (pt)	2014-10-14
CA2683933A1 (fr)	2008-12-04
HRP20100573T1 (hr)	2010-11-30
WO2008145842A3 (fr)	2009-01-22
AU2008257323A1 (en)	2008-12-04
FR2915197B1 (fr)	2009-06-12
UY31036A1 (es)	2008-11-28
DK2146991T3 (da)	2010-11-22
EP2146991A2 (de)	2010-01-27
US7868007B2 (en)	2011-01-11
AR066103A1 (es)	2009-07-22
TW200906401A (en)	2009-02-16
EP2146991B1 (de)	2010-07-28
MX2009011215A (es)	2009-11-02
SI2146991T1 (sl)	2010-11-30
IL201416A0 (en)	2010-05-31
RS51462B (en)	2011-04-30
DE602008001981D1 (de)	2010-09-09
KR20090130060A (ko)	2009-12-17
RU2009142430A (ru)	2011-05-27

Legal Events

Date

Code

Title

Description

2011-02-15

UEP

Publication of translation of european patent specification

Ref document number: 2146991

Country of ref document: EP

Publication	Publication Date	Title
ATE475661T1 (de)	2010-08-15	Triazolopyridin-carboxamid-derivate sowie ihre herstellung und therapeutische verwendung
ATE467633T1 (de)	2010-05-15	2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung
ATE372998T1 (de)	2007-09-15	1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung
ATE530553T1 (de)	2011-11-15	Zytotoxische mittel mit neuen tomamycin-derivaten und ihre therapeutische verwendung
ATE461930T1 (de)	2010-04-15	Harnstoffderivate von tropan, ihre herstellung und ihre therapeutische anwendung
ATE453637T1 (de)	2010-01-15	N-(aminoheteroaryl)-1h-indol-2-carboxamid- derivate sowie deren herstellung und therapeutische anwendung
ATE531712T1 (de)	2011-11-15	Substituierte aryloxazole und ihre verwendung
ZA200906062B (en)	2010-05-26	Benzimidazole derivatives and methods of use thereof
ATE440609T1 (de)	2009-09-15	Binäre hyaluronsäure-gemische und ihre therapeutische verwendung
IL195906A0 (en)	2009-09-01	Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
BR112012001344A2 (pt)	2016-03-15	derivados de 17hidróxi-17-pentafluoroetil-estra-4,9(10)-dieno-11-arila, método de produção destes e uso destes para o tratamento de doenças
ATE459608T1 (de)	2010-03-15	Oxopiperidinderivate, ihre herstellung und therapeutische verwendung
ATE502035T1 (de)	2011-04-15	2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung
ATE512970T1 (de)	2011-07-15	Dimere von artemisininderivaten, deren herstellung und deren therapeutische verwendung
ATE420081T1 (de)	2009-01-15	Trifluormethylbenzamidderivate und therapeutische verwendungen dafür
ATE548349T1 (de)	2012-03-15	In stellung 3 disubstituierte indol-2-on- pyridinderivate, ihre herstellung sowie ihre therapeutische anwendung
ATE423119T1 (de)	2009-03-15	Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung
ATE540023T1 (de)	2012-01-15	Neuartige 3-aminoalkyl-1,3-dihydro-2h-indol-2-on- derivate, ihre herstellung und therapeutische verwendung
ATE520654T1 (de)	2011-09-15	Polypyrrol-derivate, ihre herstellung und ihre therapeutische verwendung
ATE499351T1 (de)	2011-03-15	Aryl- und heteroaryl-ethyl-acylguanidinderivate, ihre herstellung und ihre therapeutische anwendung
ATE529426T1 (de)	2011-11-15	N-phenyl-imidazo(1,2-a)pyridincarboxamid- verbindungen, ihre herstellung sowie ihre therapeutische anwendung
DK2118104T3 (da)	2013-04-08	Azabicycloalkanderivater, fremstilling og terapeutisk anvendelse heraf
EP2157089A4 (de)	2011-08-17	Therapeutische anwendungen von imidazol-5-carbonsäurederivaten
DE602006007702D1 (de)	2009-08-20	Polymernitroxide sowie ihre herstellung und verwendung
IL178444A0 (en)	2007-02-11	6-substituted pyridoindolone derivatives production and therapeutic use thereof